Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PetMed Express, Inc.
  6. News
  7. Summary
    PETS   US7163821066

PETMED EXPRESS, INC.

(PETS)
  Report
Real-time Estimate Cboe BZX  -  05/23 03:06:33 pm EDT
20.41 USD   +2.28%
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PetMed Express, Inc. Provides Sales Guidance for the Year 2022

01/24/2022 | 04:30pm EDT
share with twitter
share with LinkedIn
share with facebook

PetMed Express, Inc. provided sales guidance for the year 2022. The company expects to see stronger reorder sales in 2022 as its AutoShip revenue continues to grow.


© S&P Capital IQ 2022
All news about PETMED EXPRESS, INC.
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosu..
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/10Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight ..
MT
05/09PETMED : Fiscal Q4 Earnings Snapshot
AQ
05/09TRANSCRIPT : PetMed Express, Inc., Q4 2022 Earnings Call, May 09, 2022
CI
05/09PetMed Express Reports Lower Fiscal Q4 Earnings, Sales
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 EPS $0.30, vs. Street Est of $0.25
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 Revenue $66M
MT
05/09PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declare..
GL
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2022 277 M - -
Net income 2022 20,2 M - -
Net cash 2022 113 M - -
P/E ratio 2022 20,2x
Yield 2022 6,07%
Capitalization 404 M 404 M -
EV / Sales 2022 1,05x
EV / Sales 2023 1,02x
Nbr of Employees 219
Free-Float 93,2%
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 19,95 $
Average target price 24,00 $
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Ronald J. Korn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-21.02%404
RAIA DROGASIL S.A.-24.69%6 194
AIN HOLDINGS INC.-0.17%1 571
QOL HOLDINGS CO., LTD.-14.14%346
HLS THERAPEUTICS INC.-10.73%339
RITE AID CORPORATION-61.74%313